Name
SS8-01A: New Drug Approvals for HR+ Metastatic Breast Cancer: Antibody Drug Conjugates - (Dato-DXd) & (T-DXd) - Part 1 - Commentary By: Ruth O'Regan, MD
Date & Time
Wednesday, December 3, 2025
Speakers
Virtual Session Link
Total Minutes
04:59
OnDemand Video URL